HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ethylpyridinium

RN given refers to parent cpd

Also Known As:

N-ethylpyridinium; N-ethylpyridinium tetrafluoroborate; N-ethylpyridinium trifluoroacetate; ethylpyridinium bromide

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Pyridinium Compounds: 5
      - ethylpyridinium: 3

Experts

1.	Crapo, James D: 1 article (07/2019)
2.	Gad, Shayne C: 1 article (07/2019)
3.	Mujer, Cesar V: 1 article (07/2019)
4.	Spainhour, Charles B: 1 article (07/2019)
5.	Sullivan, Dexter W: 1 article (07/2019)
6.	Deng, Rui: 1 article (01/2019)
7.	Fang, Erhu: 1 article (01/2019)
8.	Huang, Yongming: 1 article (01/2019)
9.	Li, Shijun: 1 article (01/2019)
10.	Liu, Ying: 1 article (01/2019)

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 01/01/2019 - "Accumulating evidence demonstrates that MnTE-2-PyP (chemical name: manganese(III) meso-tetrakis-(N-ethylpyridinium-2-yl), a superoxide dismutase (SOD) mimetic, inhibits TGF-β signaling; however, its ability to inhibit TGF-β-induced EMT in colorectal cancer has not yet been explored. "
2.	Psoriasis (Pustulosis Palmaris et Plantaris) 07/01/2019 - "Since our earlier publication (Gad et al, 2013), BioMimetix has advanced BMX-010 (Manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin or MnTE020PyP; CASRN 219818-60-7) into clinical development as a topical agent for the treatment of psoriasis, atopic dermatitis, and pruritus (idiopathic nonspecific itch). "
3.	Pruritus (Itching) 07/01/2019 - "Since our earlier publication (Gad et al, 2013), BioMimetix has advanced BMX-010 (Manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin or MnTE020PyP; CASRN 219818-60-7) into clinical development as a topical agent for the treatment of psoriasis, atopic dermatitis, and pruritus (idiopathic nonspecific itch). "
4.	Neoplasms (Cancer) 01/01/1979 - "The binding characteristics of the cancer chemotherapeutic Cain's quinolinium 6-amino-1-ethyl-4-[p-[[p-[(1-ethylpyridinium-4-yl) amino] phenyl] carbamoyl]-anilino]-quinolinium dibromide (NSC 113089) to lipid extracts from rat kidney, liver, heart and skeletal muscle has been studied. "
5.	Atopic Dermatitis (Atopic Eczema) 07/01/2019 - "Since our earlier publication (Gad et al, 2013), BioMimetix has advanced BMX-010 (Manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin or MnTE020PyP; CASRN 219818-60-7) into clinical development as a topical agent for the treatment of psoriasis, atopic dermatitis, and pruritus (idiopathic nonspecific itch). "

Related Drugs and Biologics

1.	Manganese
2.	Superoxide Dismutase
3.	Porphyrins
4.	Lipids
5.	manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin
6.	Cain quinolinium
7.	quinolinium dibromide (QdB)